Medicinal Research Reviews

1.5k papers and 101.0k indexed citations i.

About

The 1.5k papers published in Medicinal Research Reviews in the last decades have received a total of 101.0k indexed citations. Papers published in Medicinal Research Reviews usually cover Molecular Biology (785 papers), Oncology (219 papers) and Organic Chemistry (213 papers) specifically the topics of Computational Drug Discovery Methods (82 papers), Receptor Mechanisms and Signaling (82 papers) and Chemical Synthesis and Analysis (55 papers). The most active scholars publishing in Medicinal Research Reviews are Erik De Clercq, Kuo‐Hsiung Lee, Susan L. Morris‐Natschke, Binghe Wang and Claudiu T. Supuran.

In The Last Decade

Fields of papers published in Medicinal Research Reviews

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Medicinal Research Reviews. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Medicinal Research Reviews

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Medicinal Research Reviews. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Medicinal Research Reviews with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025